课题基金 / 基金详情

Effect of Granulocyte Colony-Stimulating Factor Treatment at a Low Dose but Long Duration in Patients with Coronary Heart Disease

Effect of Granulocyte Colony-Stimulating Factor Treatment at a Low Dose but Long Duration in Patients with Coronary Heart Disease
低剂量长疗程粒细胞集落刺激因子治疗冠心病患者的效果
批准号:
16590668
负责人:
NISHIGAKI Kazuhiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

NISHIGAKI Kazuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
在动物模型中,粒细胞集落刺激因子(G-CSF)可改善梗死后心功能。然而,在对心绞痛和急性心肌梗死(AMI)患者的初步研究中,高剂量的G-CSF经常引起冠状动脉闭塞或再狭窄,但低剂量的G-CSF没有显示出显著的有益作用。我们假设,一个低剂量,但持续时间长的G-CSF将有一个有益的效果,没有严重的并发症,患者顽固性心绞痛。方法和结果22例心绞痛患者随机分为G-CSF和非G-CSF对照组,分别。皮下注射重组G-CSF,每天一次,持续10天。外周血中的白细胞计数控制在约30,000/□l。一个月后,G-CSF治疗组患者的胸痛有所改善。T1 -201单光子发射计算机断层扫描(SPECT)显示G-CSF治疗组的%摄取增加,范围和严重程度评分降低。治疗前外周血CD_(34)阳性细胞数为0.6个/μl,治疗后增至3.9个/μl。
英文摘要
BackgroundIn animal models, granulocyte colony-stimulating factor (G-CSF) improves post-infarct cardiac function. However, in pilot studies of the patients with angina and acute myocardial infarction (AMI), G-CSF at a high dose frequently induced coronary occlusion or restenosis, but those at a low dose showed no significant beneficial effect. We hypothesized that a low dose but long duration of G-CSF will have a beneficial effect without serious complications to patients with intractable angina pectoris.Methods and Results22 patients with angina were randomly assigned into G-CSF and non-G-CSF control groups, respectively. Recombinant G-CSF was subcutaneously injected once a day for 10 days. The leukocyte counts in the peripheral blood were controlled at approximately 30,000/□l. One month later, chest pain in the patients improved in the G-CSF-treated group. Tl-201 single photon emission computed tomography (SPECT) revealed the increased %uptake and the reduced extent and severity scores in the G-CSF-treated group. The number of CD34 positive cells in the peripheral blood was 0.6/μl before treatment and increased to 3.9/μl after the therapy.ConclusionsA low dose but long duration of G-CSF treatment may have a beneficial effect without any serious complications in patients with angina pectoris.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Sarpogrelate, a serotonin blocker, has a pharmacological preconditioning effect in patients with coronary artery disease.
沙格雷酯是一种血清素阻滞剂,对冠状动脉疾病患者具有药理学预处理作用。
DOI: --
发表时间: 2004
期刊: Circ J 68(1)
影响因子: --
作者: [Horibe E, et al.]
通讯作者: et al.
DOI: 10.1253/circj.70.430
发表时间: 2006-04-01
期刊: CIRCULATION JOURNAL
影响因子: 3.3
作者: [Suzuki, K, Nagashima, K, Fujiwara, H]
通讯作者: Fujiwara, H
Assessment of coronary intervention in Japan from the Japanese coronary intervention study (JCIS) group-comparison between 1997 and 2000-.
日本冠状动脉介入研究(JCIS)组对日本冠状动脉介入的评估——1997年与2000年的比较——。
DOI: --
发表时间: 2004
期刊: Circ J 68(3)
影响因子: --
作者: [Nishigaki K, et al.]
通讯作者: et al.
Assessment of acute myocardial infarction in Japan from the Japanese coronary intervention study (JCIS) group.
日本冠状动脉介入研究 (JCIS) 小组对日本急性心肌梗死的评估。
DOI: --
发表时间: 2004
期刊: Circ J 68(6)
影响因子: --
作者: [Nishigaki K, et al.]
通讯作者: et al.
共 11 条
    Development of the comprehensive strategy with using
    • 批准号:
      24591044
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      NISHIGAKI Kazuhiko
    • 依托单位:
    Soluble Fas, an inhibitor of apoptosis, gene therapy using adenovirus vector for chronic congestive heart failure
    • 批准号:
      13670698
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      NISHIGAKI Kazuhiko
    • 依托单位:
    Plasma soluble Fas, an inhibitor of apoptosis, definitely improves long-term prognosis of patients with chronic heart failure
    • 批准号:
      11670669
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      NISHIGAKI Kazuhiko
    • 依托单位:
    海外基金